Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks.

Peng, Yong; Jin, Hong; Xue, Ya-Hui; Chen, Quan; Yao, Shun-Yu; Du, Miao-Qiao; Liu, Shu

Peng, Yong; Jin, Hong; Xue, Ya-Hui; Chen, Quan; Yao, Shun-Yu; Du, Miao-Qiao; Liu, Shu.

Afiliación

Peng Y; Neurology Department, The First Affiliated Hospital of Hunan Traditional Chinese Medical College, Zhuzhou, Hunan, China.
Jin H; Neurology Department, The Third Affiliated Hospital of Hunan University of Chinese Medicine, Zhuzhou, Hunan, China.
Xue YH; Neurology Department, The First Affiliated Hospital of Hunan Traditional Chinese Medical College, Zhuzhou, Hunan, China.
Chen Q; Neurology Department, The Third Affiliated Hospital of Hunan University of Chinese Medicine, Zhuzhou, Hunan, China.
Yao SY; Neurology Department, The First Affiliated Hospital of Hunan Traditional Chinese Medical College, Zhuzhou, Hunan, China.
Du MQ; Neurology Department, The Third Affiliated Hospital of Hunan University of Chinese Medicine, Zhuzhou, Hunan, China.
Liu S; Neurology Department, The First Affiliated Hospital of Hunan Traditional Chinese Medical College, Zhuzhou, Hunan, China.

Front Aging Neurosci ; 15: 1206572, 2023.

Article en En | MEDLINE | ID: mdl-37600514

Palabras clave

Alzheimer's disease; clinical trials; mitochondria-targeting; multi-targets; tau protein; ß-amyloid protein

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Aging Neurosci Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google